440 filings
Page 11 of 22
8-K
kfuamv
13 Nov 18
Other Events
5:18pm
424B5
7hdr nx4mawpaz87d
13 Nov 18
Prospectus supplement for primary offering
5:16pm
424B5
9zzmilfmd125928id
9 Nov 18
Prospectus supplement for primary offering
7:06am
8-K
pb92p
2 Nov 18
AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:14pm
8-K
glii chrltj5
2 Nov 18
First and only sufentanil sublingual tablet approved for acute pain in healthcare settings
3:05pm
8-K
xsdj2ol974mqz
2 Aug 18
AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:05pm
8-K
fvk5f
13 Jul 18
Other Events
4:03pm
424B5
lbmvyuo6d33u 4p
13 Jul 18
Prospectus supplement for primary offering
4:03pm
8-K
8egrsv
11 Jul 18
Results of Operations and Financial Condition
4:18pm
424B5
bbuth
11 Jul 18
Prospectus supplement for primary offering
4:16pm
8-K
tt612kujq11 wzf04gs
2 Jul 18
AcelRx receives European Commission approval for DZUVEOTM
4:51pm
8-K
vacv7plmf93e507w5
15 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
loukw9l272y8h96
23 Apr 18
Additional proxy soliciting materials
12:00am
8-K
00jjt3
12 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
wzvfo7xpm77z233s5g
27 Mar 18
Departure of Directors or Certain Officers
12:00am
S-8
2iiemjudn27wkpz8i l0
9 Mar 18
Registration of securities for employees
12:00am